Skip to content
Updated FDA Recognition of CLSI Breakpoints (JCM ed.) episode artwork

May 30, 2025 52 min

Updated FDA Recognition of CLSI Breakpoints (JCM ed.)

from Editors in Conversation Hosted by Alexander McAdam, Elitza Theel, Romney Humphries, Patricia Simner

Oversight and guidance for performing antibiotic susceptibility testing can be bewildering. There is an alphabet soup of agencies and bodies involved: FDA, CLSI, and USCAST, to name a few here in the US. How does the Food and Drug Administration, which has regulatory authority over AST, work with a nimble group like the Clinical Laboratory Standards Institute? Guests: Romney Humphries, Ph.D., D(ABMM), M(ASCP) Patricia Simner, Ph.D., D(ABMM) Links: Major updates to FDA-recognized Clinical and Laboratory Standards Institute breakpoints are a win for the fight against antimicrobial resistance Join ASM for up to 50% off the publication fees when you publish in JCM or any of the ASM journals. Attend ASM Microbe This episode of Editors in Conversation is brought to you by the Journal of Clinical Microbiology and hosted by JCM Editor in Chief, Alex McAdam and Dr. Elli Theel. JCM is available at https://jcm.asm.org and on https://twitter.com/JClinMicro. Visit journals.asm.org/journal/jcm to read articles and/or submit a manuscript. Follow JCM on Twitter/𝕏 via @JClinMicro

Episode details come from the podcast's RSS feed.

Embed this episode

Ready to play

Updated FDA Recognition of CLSI Breakpoints (JCM ed.)

0:00 52:12

No transcript yet.

Requests help us decide what to transcribe next.

Frequently asked questions

How long is this episode of Editors in Conversation?

This episode is 52 minutes long.

When was this Editors in Conversation episode published?

This episode was published on May 30, 2025.

Can I download this Editors in Conversation episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.